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Shared Quality Data Results in Increased Protamine Use and Reduced
Bleeding Complications After Carotid Endarterectomy in the Vascular
Study Group of New England
Reshma B. Patel,1 Peter Beaulieu,2 Philip P. Goodney,3 Andrew C. Stanley,1
Jack L. Cronenwett,3 David H. Stone,3 Daniel J Bertges1. 1University of
Vermont College of Medicine, Burlington, Vt; 2University of New England
College of Osteopathic Medicine, Biddeford, Me; 3Dartmouth Hitchcock
Medical Center, Lebanon, NH
Introduction and objectives: The study goal was to evaluate whether
protamine usage after carotid endarterectomy (CEA) increased within the
Vascular Study Group of New England (VSGNE) in response to the
VSGNE presentation (April 2009), the Society for Vascular Surgery presen-
tation (June 2009), and Journal of Vascular Surgery publication (March
2010) “Protamine reduces bleeding complications associated with carotid
endarterectomy without increasing the risk of stroke.”
Methods: We reviewed protamine usage during 9882 CEAs excluding
concomitant coronary bypass within the VSGNE from January 2003 to June
2011. Protamine usage was evaluated biannually using statistical process
control charting. Trends in surgeon use before (n 67) and after 2009 (n
113) were categorized as rare, selective, or routine. End points included
postoperative myocardial infarction (POMI), stroke, death, and reoperation
for bleeding.
Results: Protamine was administered during 54% of procedures, in-
creasing from 46% before 2009 to 61% after 2009 (P .001). The increase
in protamine use surpassed the upper control limit of three standard devia-
tions in 2009 coincident with presentation and publication of the VSGNE
study (Fig). Surgeon usage shifted from rare, selective, and routine over time
from 45%, 18%, and 37% to 24%, 35% and 42%, respectively. Reoperation for
bleeding decreased (0.5% vs 1.4%, P  .001) with similar rates of POMI
(1.0% vs 1.2%, P  .52), stroke, or death (1.1% vs 1.1%, P  .796) in
protamine treated vs untreated patients, respectively. Reoperation for bleed-
ing decreased significantly from 1.2% before 2009 to 0.6% after 2009 (P 
.003).
Conclusions: Protamine use increased by VSGNE surgeons coincident
with presentation of VSGNE-derived data showing the benefit of protamine.
Improvements in the process of care can be achieved in regional quality
groups by sharing safety and efficacy data.
Timing of Perioperative Events Following Carotid Endarterectomy:
In-Hospital vs Post-Discharge Adverse Events
Margriet Fokkema,1 Rodney P. Bensley,1 Ruby C. Lo,1 Allan D. Hamdan,1
Mark C. Wyers,1 Gert Jan de Borst,2 Frans L. Moll,2 Marc L. Schermer-
horn1. 1Beth Israel Deaconess Medical Center, Boston, Mass; 2University
Medical Center Utrecht, Utrecht, The Netherlands
Introduction and objectives: Most studies based on state and nation-
wide registries evaluating perioperative outcome after carotid endarterec-
tomy (CEA) rely on hospital discharge data. Therefore, true 30-day com-
plication risk after carotid revascularization may be underestimated.
Methods: We used the National Surgical Quality Improvement Pro-
gram database 2005-2010 to assess the in-hospital and postdischarge rate of
any stroke and stroke/death at 30 days after CEA and identified predictors
for the timing of these events. Univariate analysis including demographics
and preoperative variables served as a base (threshold P  .2) for multivari-
able analysis to identify predictors associated with outcome.
Results: A total of 35,916 patients (asymptomatic and symptomatic;
59% men, median age, 72 years) underwent CEA during 2005 to 2010. The
30-day stroke rate was 1.6% (n 591) and the combined stroke/death rate
was 2.2% (n  792), and 31.2% of strokes (0.5%) and 40.9% of combined
events (0.9%) took place after hospital discharge (median days to stroke, 8
[interquartile range, 11]). Women were more likely to have postdischarge
events than men (stroke, 38.1% vs 29.0%, P .005; stroke/death, 42.8% vs
40.0%, P  .009). Renal failure was also predictive for postdischarge stroke
(odds ratio, 3.16; 95% confidence interval, 1.54-6.47), whereas those un-
dergoing emergency procedures and redo-CEA were more likely to have
in-hospital events.
Conclusions: One in three perioperative strokes and deaths after CEA
are missed when only hospital admission data are analyzed. This emphasizes
the need for reporting and comparing 30-day outcomes. Selected subgroups
at increased risk for either in-hospital or postdischarge events merit further
investigation and may benefit from changes in management. Particularly in
woman and those with renal failure, we need to be alert to the ongoing risk
of adverse events after hospital discharge.
The Effect of Postoperative Stroke and Myocardial Infarction on
Long-Term Survival After Carotid Revascularization
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Introduction and objectives: The largest randomized controlled trial
comparing the efficacy of carotid endarterectomy (CEA) vs carotid artery
stenting (CAS) showed equivalent outcomes for the composite end point of
postoperative stroke, myocardial infarction (MI), or death. However, CAS
had a higher risk of postoperative stroke, and CEA had a higher risk of MI.
This analysis of long-term survival after carotid revascularization tested the
hypothesis that postoperative stroke reduced long-term survival more than
postoperative MI.
Methods: The Vascular Study Group of New England was used to
identify all CEA and CAS procedures from 2003 to 2011. Patients were
stratified according to whether they experienced a minor or major postop-
erative stroke, MI (troponin elevation, electrocardiographic changes and/or
clinical symptoms), or neither. Primary study end points were 1- and 5-year
survival. Multivariable Cox proportional hazards models compared the
magnitude of effect of stroke and MI on survival.
Results: Of 8315 patients, 81 (1.0%) experienced postoperative MI
and 63 (0.8%) experienced stroke (37% major, 64% minor). Survival signif-
icantly differed at 1 year: MI, 84%; stroke, 77%, neither, 96% (log-rank, P
.0001). After adjusting for confounders, stroke was an independent predic-
tor of death at 1 year (hazard ratio [HR], 6.6; 95% confidence interval [CI],
3.7-12; P  .0001), as was MI (HR, 3.6; 95% CI, 2-6.8; P  .0001). At 5
years, on multivariable modeling, stroke was again an independent predictor
of death (HR, 2.7; 95% CI, 1.7-4.3; P .0001), with a magnitude of effect
similar to that of MI (HR, 2.8; 95% CI, 1.8-4.3; P  .0001).
Conclusions: Postoperative stroke conferred a sixfold increased hazard
of death at 1 year, which was nearly twice that associated with postoperative
MI. By 5 years, survival curves converged and the disadvantage conferred by
stroke was similar to that by MI. This study demonstrates that stroke
portends a significantly worse survival prognosis than MI within the first year
after carotid revascularization.
Race As a Predictor of Morbidity and Mortality After Carotid
Endarterectomy
Hilary A. Brown, Michael Sullivan, Richard Gusberg, Alan Dardik, Julie Ann
Sosa, Jeffrey Indes. Yale University, New Haven, Conn
Introduction and objectives: Racial disparities in the outcomes of
patients undergoing carotid endarterectomy (CEA) have been reported. We
sought to examine the contemporary relationship between race and out-
comes, as well as to report postdischarge events after CEA.
Methods: American College of Surgeons-National Surgical Quality
Improvement Program data were reviewed to identify all CEAs performed
from 2005 to 2010. The influence of race on outcomes was examined.
Multivariate analysis was performed using variables found to be significant
on bivariate analysis. The primary outcomes were stroke and mortality.
Secondary outcomes were other 30-day complications, including postdis-
charge events.
Results: CEA was performed on 29,114 white patients (95.7%) and
1316 black patients (4.3%). The overall stroke and mortality rates were
1.65% and 0.7%, respectively. The stroke rate was 1.6% for whites and 2.5%
for blacks (P  .0009). The 30-day mortality rate was 0.7% for white
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